Gene Therapy May Lower Stroke Risk in Sickle Cell Patients

gene Therapy Shows Promise in Reducing Stroke Risk for Sickle Cell Disease Patients

Memphis,TN – June 30,2025 – A groundbreaking new study from St. Jude Children’s Research Hospital suggests gene therapy could significantly reduce stroke risk in patients with sickle cell disease.The research, published today in the American Journal of Hematology, focuses on improving a key factor contributing to stroke: inadequate oxygen delivery to the brain.

Many individuals with sickle cell disease experience brain ischemia – a condition